Oric Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -264 | -320 | ||
EBITDA | -45,032 | -35,497 | -30,185 | -32,299 |
EBIT | -45,296 | -35,767 | -30,505 | -32,587 |
Net Income | -41,492 | -35,767 | -30,505 | -32,587 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -31,961 | -32,440 | -22,870 | -25,147 |
Cash | 37,483 | 56,396 | 45,669 | 49,668 |
Basic Shares | 108,012 | 105,472 | 87,793 | 98,953 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,220 | -1,107 | -1,032 | -966 |
EBITDA | -128,248 | -126,740 | -99,665 | -85,801 |
EBIT | -129,468 | -127,847 | -100,697 | -86,767 |
Net Income | -129,468 | -127,847 | -100,697 | -89,122 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -159,166 | |||
Free Cash Flow | -114,079 | -113,850 | -86,537 | -77,221 |
Cash | 45,669 | 59,406 | 23,384 | 66,840 |
Basic Shares | 87,793 | 69,727 | 51,450 | 39,655 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.38 |
2026-03-31 | -$0.34 |
2025-12-31 | -$0.30 |
2025-09-30 | -$0.33 |